Journal article
Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological malignancies (Review).
- Abstract:
-
Background Patients with haematological disorders are frequently at risk of severe or life-threatening bleeding as a result of thrombocytopenia. This is despite the routine use of prophylactic platelet transfusions (PlTx) to prevent bleeding once the platelet count falls below a certain threshold. PlTx are not without risk and adverse events may be life-threatening. A possible adjunct to prophylactic PlTxs is the use of antifibrinolytics, specifically the lysine analogues tranexamic acid (TX...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 450.7KB, Terms of use)
-
- Publisher copy:
- 10.1002/14651858.CD009733.pub2
Authors
- Publisher:
- Wiley
- Journal:
- Cochrane Database of Systematic Reviews More from this journal
- Volume:
- 2013
- Issue:
- 7
- Pages:
- CD009733
- Publication date:
- 2013-07-29
- DOI:
- EISSN:
-
1469-493X
- ISSN:
-
1469-493X
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:389997
- UUID:
-
uuid:92a68372-9345-49b8-a377-26b7ff796548
- Local pid:
-
pubs:389997
- Source identifiers:
-
389997
- Deposit date:
-
2015-01-22
Terms of use
- Copyright holder:
- The Cochrane Collaboration
- Copyright date:
- 2013
- Notes:
- Copyright © 2013 The Cochrane Collaboration. Published by John Wiley and Sons, Ltd. This is the publisher's version of the article. The final version is available online from Wiley at: [10.1002/14651858.CD009733.pub2].
If you are the owner of this record, you can report an update to it here: Report update to this record